Sophie Gourgou Selected Research

Sophie Gourgou Research Topics

Disease

21	Neoplasms (Cancer) 12/2023 - 03/2002
10	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2005
6	Carcinoma (Carcinomatosis) 10/2023 - 02/2004
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2003
5	Fibrosis (Cirrhosis) 09/2023 - 04/2014
5	Rectal Neoplasms (Rectal Cancer) 01/2023 - 12/2019
5	Adenocarcinoma 01/2021 - 03/2002
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 02/2004
2	Disease Progression 01/2023 - 01/2019
2	Cardiotoxicity 01/2022 - 04/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2015
2	Fatigue 10/2020 - 07/2019
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 07/2008
2	Colonic Neoplasms (Colon Cancer) 02/2004 - 04/2003
1	Exanthema (Rash) 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2022
1	Polyuria 04/2022
1	Dysuria 04/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Neutropenia 01/2021
1	Myocardial Infarction 01/2021
1	Sudden Death 01/2021
1	Triple Negative Breast Neoplasms 07/2020
1	Hemorrhagic Stroke 01/2020
1	Ischemia 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Peritoneal Diseases 06/2019
1	Mesothelioma 06/2019
1	Second Primary Neoplasms (Neoplasms, Second) 12/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Hypertrophy 04/2014
1	Amyloidosis 04/2014
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 04/2014
1	Cardiomegaly (Heart Hypertrophy) 04/2014

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
4	folfirinoxIBA 01/2023 - 01/2017
4	Carcinoembryonic AntigenIBA 10/2022 - 04/2003
4	Gemcitabine FDA Link 10/2022 - 12/2011
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2019 - 12/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2003
3	Docetaxel (Taxotere)FDA Link 12/2019 - 04/2013
3	Leucovorin (Folinic Acid)FDA Link 01/2019 - 08/2007
3	CytokinesIBA 11/2007 - 04/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2007 - 04/2003
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2019
2	AntigensIBA 10/2022 - 01/2017
2	CarbohydratesIBA 10/2022 - 01/2017
2	3-acetylpyridine adenine dinucleotide (APAD)IBA 10/2020 - 07/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2018 - 08/2007
2	Letrozole (Femara)FDA LinkGeneric 03/2010 - 01/2005
1	Trinitrotoluene (TNT)IBA 10/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 10/2022
1	Biological FactorsIBA 10/2022
1	ChemokinesIBA 07/2020
1	Hormones (Hormone)IBA 07/2020
1	Chemokine ReceptorsIBA 07/2020
1	LigandsIBA 07/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	eribulin FDA Link 12/2019
1	Capecitabine (Xeloda)FDA Link 12/2019
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	PlatinumIBA 01/2019
1	rilotumumabIBA 01/2019
1	thiamine triphosphorate (TTP)IBA 10/2018
1	Therapeutic UsesIBA 01/2017
1	Abiraterone AcetateIBA 04/2015
1	AndrogensIBA 04/2015
1	Amyloid (Amyloid Fibrils)IBA 04/2014
1	erythromycin propionate-N-acetylcysteinateIBA 04/2014

Therapy/Procedure

21	Radiotherapy 12/2023 - 03/2002
10	Drug Therapy (Chemotherapy) 01/2021 - 12/2011
9	Therapeutics 01/2023 - 01/2005
4	Neoadjuvant Therapy 10/2023 - 01/2021
3	Chemoradiotherapy 01/2023 - 12/2019
3	Proctectomy 03/2022 - 03/2002
2	Induction Chemotherapy 10/2023 - 01/2023
2	Adjuvant Radiotherapy 09/2023 - 03/2018
2	Conformal Radiotherapy 01/2022 - 07/2008
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 10/2010
2	Adjuvant Chemotherapy 01/2021 - 10/2020
1	Retreatment 12/2022
1	Aftercare (After-Treatment) 04/2022
1	Adjuvant Chemoradiotherapy 03/2022
1	Brachytherapy 03/2022
1	Polypharmacy 12/2019
1	Hyperthermic Intraperitoneal Chemotherapy 06/2019
1	Cytoreduction Surgical Procedures 06/2019
1	Combination Drug Therapy (Combination Chemotherapy) 12/2018
1	Time-to-Treatment 10/2018
1	Segmental Mastectomy (Lumpectomy) 03/2018
1	Castration 04/2015
1	Duration of Therapy 04/2015